Kawada M, Nobeyama Y, Goto Y, Nakama K, et al. Absence of toxic epidermal necrolysis recurrence with pembrolizumab re-challenge in a patient with a positive lymphocyte transformation test. J Dermatol 2020 Aug 20. doi: 10.1111/1346-8138.15572.
PMID: 32815211